This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

American Medical, Global Crossing: Small-Cap Winners

Stocks in this article: AMMD GLBC HRZ TSTY BLTI PRAN REE

NEW YORK ( TheStreet) -- Small-caps were rallying Monday on a flurry of deal activity. Shares of American Medical Systems (AMMD) were soaring 32% to $29.47 on volumes nearing 30 million in forenoon trading, after Endo Pharmaceuticals (ENDP) said it will acquire the incontinence drug manufacturer for $2.9 billion or $30 per share.

Communication solutions provider Global Crossing (GLBC) saw its stock jump 57% to $23.40 after Level3 Global Communications (LVLT) agreed to acquire the company for $1.9 billion or $23.04 per share. The deal will combine two unprofitable companies with total revenue of $6.26 billion as of last year, and cut annualized capital spending by about $40 million, according to the statement.

Flower Foods (FLO) picked up Tasty Baking Company (TSTY) for $4 a share, or roughly $165 million. The acquisition is expected to strengthen Flowers' snack cake business and expand its geographic reach. Tasty's stock more than doubled, gaining $2.35 to $3.96. Shares of Flower Foods were up 2.3% at $28.29.

Container shipping company Horizon Lines (HRZ) was up 13.7% on heightened volumes. The company has agreed to a settlement over business practices involving its cargo service with Puerto Rico. Horizon Lines is looking at options to refinance and restructure to avoid a debt default, according to press reports. Horizon has said it expects to default on its loans due to a $45 million fine for price-fixing in the Jacksonville-Puerto Rico trade lane.

Shares of dental laser manufacturer Biolase (BLTI), was up 7% at $6.16. The company announced Friday that it has executed an agreement for the sale of 320,000 shares of its common stock at $5.60 per share to institutional investors in a registered direct offering for approximately $1.80 million in gross proceeds.

Shares of Prana Biotech (PRAN) were up 5% at $2.52 after it said that it had secured a key patent for its PBT2 drug in Japan.

Rare metal stocks were once again in play with shares of Rare Element Resources (REE) and Avalon Rare Metals (AVL) gaining 10.3% and 7.5% respectively.

--Written by Shanthi Bharatwaj in New York

>To contact the writer of this article, click here: Shanthi Bharatwaj.

>To follow the writer on Twitter, go to

>To submit a news tip, send an email to:

Disclosure: TheStreet's editorial policy prohibits staff editors and reporters from holding positions in any individual stocks.

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,030.21 +6.04 0.03%
S&P 500 2,081.88 -0.29 -0.01%
NASDAQ 4,773.4720 +8.0480 0.17%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs